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Background: Systemic lupus erythematosus (SLE) is a chronic inflammatory disorder that 
affects the kidney in around 50% of patients
Objectives: The aim of this study was to assess CD147 expression with various pathologic 
lesions, biochemical and demographic data in patients with classes III and IV lupus 
nephritis.
Patients and Methods: These patients with lupus nephritis classes II and IV by renal 
biopsy and pathology were enrolled in this study. The strength of CD147 staining on 
tubules, Bowman’s capsules, vessels and tuft of glomeruli was expressed as proportion of 
involvement. 
Results: In this study, 23 renal biopsies for lupus nephritis of classes III and IV (documented 
by immunofluorescence and light microscopic studies) were included. No significant 
difference of CD147 staining between classes was detected (P > 0.05). In addition, 
proportion of proteinuria was not related to CD147 staining in tubules, Bowman’s capsules, 
vessels and tuft of glomeruli in classes III and IV lupus nephritis (P > 0.05). There was no 
significant association of CD147 staining in tubules, Bowman’s capsules and vessels with 
serum creatinine (P > 0.05). However, an association between CD147 staining in tuft of 
glomeruli with serum creatinine was detected (r=0.623, P = 0.002). None of chronicity or 
activity percent of glomerular involvement in two classes of III or IV had a significant 
association with CD147 staining (P > 0.05). 
Conclusions: The significant association between CD147 staining in glomeruli with serum 
creatinine in lupus nephritis of classes III and IV revealed that inflammation at this area 
may have prognostic implication.
ABSTRACT
Implication for health policy/practice/research/medical education:
In a study on 23 renal biopsies for lupus nephritis of  classes III and IV, we found an association between CD147 staining in 
tuft of  glomeruli with serum creatinine (r=0.623, P=0.002).
Please cite this paper as: Amiri M, Abedini F, Baradaran A. Relationship of  CD147 kidney expression with various pathologic 
lesions, biochemical and demographic data in patients with classes III and IV of  lupus nephritis. J Nephropathol. 2018;7(3):101-
105. doi: 10.15171/jnp.2018.24.
1. Background
Systemic lupus erythematosus (SLE) is considered by 
deficit of  self-tolerance and expansion of  autoantibodies 
to nuclear self-antigens (1). SLE is a chronic inflammatory 
disorder that disturbs the kidneys in around 50% of 
patients. SLE is more predominant in females than males 
through all age groups and populaces. Lupus nephritis is 
a noteworthy contributor to mortality and morbidity in 
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individuals with SLE. The clinical presentations of  lupus 
nephritis are often delicate (1,2).
SLE gives many confronts for clinicians. The beginning 
of  disorder may be insidious, with various dissimilar 
symptoms and signs, constructing early and accurate 
diagnosis problematic (1,2). Hence, all patients with 
SLE should be considered for renal engagement at early 
diagnosis. The occurrence of  SLE and the chances of 
emerging lupus nephritis vary significantly among various 
areas of  the world and diverse races and civilizations 
(2-4). However, varying degrees of  kidney engagement 
are seen in around 60% of  patients with SLE with 
lupus nephritis (1,2). In 10% to 30% of  patients, this 
condition extended to end-stage renal disease in about 
15 years after diagnosis. The identification of  SLE is 
clinically reinforced by serology and histopathology. 
Despite the existence of  clinical criteria, Lupus nephritis 
persists a histopathological identification. The renal 
biopsy provides a suggestion for disease prognosis, 
activity, chronicity and arranging of  therapy (2-4). The 
glomerular lesions that commonly convoy SLE have 
been the topic of  interest. Morphologic lesions of  lupus 
nephritis consisted of  mesangial proliferation lonely 
(class II), endocapillary and extracapillary proliferation; 
additionally, fibrinoid necrosis, wire loops and hyaline 
thrombi or podocytopathy may be seen. In glomeruli, 
involvement may be focal (class III) or diffuse (class 
IV), global or segmental (3,4). In addition, lesions in 
tubulointerstitial area are connected with glomerular 
lesions, however, they have also been detected to 
be prognostic of  kidney outcome in lupus nephritis 
irrespective of  glomerular lesions. Thus, interstitial 
inflammation, atrophy of  the tubules and fibrosis must 
report in the pathology reports of  lupus nephritis and 
graded as mild, moderate, or severe (4,5). Recently much 
interest has been paid towards other parameters having 
prognostic implication for disease progression or patients’ 
survival. CD147, which is a transmembrane glycoprotein 
belongs to the immunoglobulin superfamily (2-4). CD147 
has been detected to have a role in some physiological and 
pathological consequences by interacting with various 
binding partners like cyclophilins or caveolin-1 (2-4). 
Recent studies have shown that CD147 has participated 
in the control of  metastatic cancers and lymphocyte 
responsiveness. In normal conditions, high expression of 
CD147 is detected only in the basolateral side of  tubular 
epithelial cells (TECs) in the kidney (5,6). The role of 
CD147 in the kidneys are different, extending from its 
role in acute renal failure which is usually associated with 
inflammation and ischemia. However, the correlation 
of  CD147 expression with tubulointerstitial injury 
and glomerular damage in lupus nephritis is not fully 
understood while studies in this regard are scare. It is 
possible that expression of  CD147 in glomeruli or in 
interstitial area encountered as a marker for progression 
of  lupus nephritis (5,6).
2. Objectives
In this study we sought to measure CD147 intensity 
staining in tubules, Bowman’s capsules, vessels and tuft 
of  glomeruli with some demographic data among lupus 
nephritis patients.
3. Patients and Methods
3.1. Patients and specimens 
This study consisted of  patients with lupus nephritis 
classes II and IV by renal biopsy. The study was 
conducted in renal pathology division of  Baradaran 
laboratory in Isfahan (Iran). Renal biopsies with fewer 
than ten glomeruli were excluded from the study. The 
SLE patients also achieved the revised American College 
of  Rheumatology (ACR) criteria for systemic lupus 
nephritis (7) as explained by their physicians. Various 
data consisted of  age, gender, proportion of  24 hours 
proteinuria and serum creatinine was also obtained from 
patients’ records.
3.2. Definition of  lupus nephritis
The diagnosis of  lupus nephritis is based on clinical and 
laboratory findings and lastly by immunofluorescence 
study by considerable positive C1q (more than 2+ 
intensity) accompanied by IgG, IgA, IgM and C3 
deposits (full-house configuration), which were semi-
quantitatively classified from zero to 3+. Renal biopsies 
were presented conferring to the 2003 ISN/RPS 
classification for LN (4,5).
3.3. Immunohistochemical analysis for CD147
To conduct immunohistochemical staining, the 4-μm-
thick sections were stained with mouse monoclonal anti-
human CD147 antibody [rabbit polyclonal to CD147; 
anti-CD147 antibody (ab64616; abcam)]. The strength of 
CD147 staining on tubules, Bowman’s capsules, vessels 
and tuft of  glomeruli was expressed as proportion of 
involvement. 
3.4. Ethical issues
This investigation was in accordance with the Declaration 
of  Helsinki. This study was conducted on paraffin 
embedded blocks of  renal biopsies to find CD147 
intensity. The ethical board committee of  national 
institute for medical research development approved this 
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study (NIMAD; http://nimad.ac.ir; Grant#943670). 
3.5. Statistical analysis
Categorical variables were stated as percentages and 
evaluated with chi-square (χ2) test. Continuous variables 
were expressed as mean ± standard deviation (SD). The 
differences between groups were evaluated by student 
t test. The reported P value was two-sided with a value 
of  less than 0.05 as statistically significant criteria. 
Pearson correlation coefficients were used for finding 
the correlation between factors. All analysis had done 
by SPSS software version 22.0 (SPSS Inc, Chicago, Ill, 
USA). 
4. Results
The study consisted of  33 cases of  renal biopsy with 
detection of  lupus nephritis, which their CD147 staining 
were obtained. Around 23 patients who were in classes 
III and IV were enrolled in the study. According to 
the similar nature of  classes III and IV regarding 
morphologic lesions and clinical presentation, thus this 
study was only conducted on patients with classes III 
and IV. All biopsies documented for lupus nephritis 
classes III and IV by IF and light microscopic studies. 
Mean age of  patients was 31.56 ± 9.72 years (minimum 
age; 11 years maximum age; 50 years). About 18 (78.3%) 
patients were female. The average of  proteinuria and 
serum creatinine were 2294.35 ± 1338.92 mg/d and 1.65 
± 0.82 mg/dL, respectively. Serum creatinine in classes 
of  III and IV was 1.21 ± 0.30 mg/dl and 1.98 ± 0.93 
mg/dL, respectively (P = 0.020). Moreover, the average 
of  proteinuria in classes of  III and IV was 1704.00 ± 
766.80 mg/d and 2748.46 ± 1527.03 mg/d, respectively 
(P = 0.062). Accordingly, the proportion of  activity in of 
classes III and class IV was 22.80 ± 25.38 versus 69.92 
± 28.12 percent (P < 0.001). Likewise, the proportion of 
chronicity in classes III and IV was 12.00 ± 9.77 versus 
11.46 ± 21.94 percent but not significant (P = 0.943). 
Furthermore, 13 cases had global lesions of  glomeruli 
of  two classes. In addition, 10 cases had focal lesions of 
glomeruli in classes of  III and IV. 
Table 1 shows the frequency distribution of  CD147 
intensity staining in areas of  tubules, Bowman’s capsules, 
vessels and tuft of  glomeruli. As the table shows, most 
of  the staining was related to CD147 staining of  renal 
tubules.
Table 2 shows the distribution of  CD147 in classes III 
and IV, with no significant difference of  CD147 staining 
between classes (P > 0.05).
Similarly, no significant differences of  CD147 staining 
in all four regions of  interstitium, tubules, vessels or 
glomeruli in global versus segmental lesions of  the 
glomeruli were detected (P > 0.05) (Table 3).
The same as Table 3, there were no significant differences 
of  CD147 staining in all four regions of  interstitium, 
tubules, vessels or glomeruli in focal versus diffuse lesions 
of  the glomeruli were detected (P > 0.05) (Table 4).
The results of  this study showed that the proportion of 
proteinuria was not related to CD147 staining in tubules, 
Bowman’s capsules, vessels and tuft of  glomeruli in 
classes III and IV lupus nephritis (P > 0.05). There was 
no significant association of  CD147 staining in tubules, 
Bowman’s capsules and vessels with serum creatinine 
(P > 0.05). None of  chronicity or activity percent of 
glomerular involvement had an association with CD147 
staining (P > 0.05). Additionally, there was no association 
Table 1.  Frequency distribution of  CD147 intensity staining in tubules, Bowman’s capsules, vessels and tuft of  glomeruli
Factor Minimum Maximum Mean Standard deviation
Interstitial area 0 30 11.96 9.62
Vessels 0 10 0.87 2.46
Glomeruli 0 70 14.78 16.13
Tubules 0 50 17.04 14.65
Table 2. Frequency distribution of  CD147 intensity staining in tubules, Bowman’s capsules, vessels and tuft of  glomeruli in 





Interstitial area 11.50 ± 8.83 12.31 ± 10.53 11.96 ± 9.62 0.847
Vessel 1.00 ± 3.16 0.77 ± 1.88 0.87 ± 2.46 0.829
Glomeruli 9.00 ± 9.37 19.23 ± 19.02 14.78 ± 16.13 0.135
Tubules 17.00 ± 15.67 17.08 ± 14.47 17.04 ± 14.65 0.990
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between ages of  patients with CD147 staining (P > 0.05). 
We found an association between CD147 staining in tuft 
of  glomeruli with serum creatinine (r=0.623, P = 0.002). 
5. Discussion
This study showed more proportion of  proteinuria, 
serum creatinine and activity percent in class IV versus 
class III. We found, most of  the CD147 staining was 
related to renal tubules. Furthermore, we found no 
significant difference of  CD147 staining between classes. 
Similarly no significant difference of  CD147 staining in 
global versus segmental lesions of  the glomeruli was 
detected. Besides, proportion of  proteinuria was not 
related to CD147 staining. Likewise, none of  chronicity 
or activity percent of  glomeruli had an association with 
CD147 staining. In this study we found an association 
between CD147 staining in tuft of  glomeruli with serum 
creatinine. 
In a study on a total of  218 lupus patients Wilson et 
al, detected class IV had worse renal survival. They 
also found, interstitial infiltration and tubular atrophy/
interstitial fibrosis (IFTA) individualistically affect kidney 
survival (3). 
In a study on 64 lupus nephritis patients, Maeda-Hori et al 
detected, in lupus nephritis tissues, CD147 presentation 
was remarkable in damaged glomeruli; however, not in 
injured tubules representing atrophy. In addition, plasma 
CD147 levels precisely reflected the histological activity 
of  the disease. They concluded that plasma CD147 
might provide admirable diagnostic capabilities to find 
the best choice of  lupus nephritis therapy, while plasma 
CD147 levels provided suitable perceptions into disease 
activity (6). 
Very few studies conducted on CD147 staining in 
lupus nephropathy. However, a similar study by Sun et 
al, on 86 kidney biopsies in IgA nephropathy, CD147 
presentation was detected in the basolateral membrane 
of  renal tubular cells. They detected a significant indirect 
relationship of  CD147 staining of  kidney tubules with 
proportion of  glomerular filtration. They also found 
a significant direct relationship of  CD147 staining of 
kidney tubular cells with serum creatinine levels and also 
with lesions of  tubulointerstitial area (8). 
Interestingly, they found that elevated CD147 expression 
was correlated with reduced kidney survival. Their study 
revealed a raised CD147 immunostaining intensity is 
an independent predictor of  renal outcome in IgA 
nephropathy. They concluded that CD147 presentation 
may predict renal prognosis in IgA nephropathy.
More recently, Mori et al evaluated the clinical efficacy of 
CD147 in biopsy-proven kidney diseases which resulted 
in chronic renal failure (9). Their patients included 538 
patients with various renal disease. They detected the 
CD147 presentation in disturbed regions of  kidney. 
6. Conclusions
The observed significant association between CD147 
staining in glomeruli with serum creatinine in lupus 
nephritis of  classes III and IV revealed that inflammation 
at this area may have a prognostic implication, while 
most of  the staining was related to CD147 staining of 
renal tubules. 
Limitations of  the study
The relatively small sample of  kidney biopsies is a 
limitation of  our investigation. We suggest further 
Table 3. CD147 intensity staining in global versus segmental lesions of  the glomeruli
Factor Global versus segmental Total P valueSegmental Global
Interstitial area 11.00 ± 9.37 12.69 ± 10.13 11.96 ± 9.62 0.686
Vessel 1.00 ± 3.16 0.77 ± 1.88 0.87 ± 2.46 0.829
Glomeruli 8.50 ± 9.73 19.61 ± 18.65 14.78 ± 16.13 0.102
Tubules 15.70 ± 16.38 18.08 ± 13.77 17.04 ± 14.65 0.709
Table 4. CD147 intensity staining in focal versus diffuse lesions of  the glomeruli
Factor Focal versus diffuse Total P valueFocal Diffuse
Interstitial area 11.50 ± 8.83 12.31 ± 10.53 11.96 ± 9.62 0.847
Vessel 1.00 ± 3.16 0.77 ± 1.88 0.87 ± 2.46 0.829
Glomeruli 9.00 ± 9.37 19.23 ± 19.02 14.78 ± 16.13 0.135
Tubules 15.70 ± 16.38 18.08 ± 13.77 17.04 ± 14.65 0.709
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studies on this aspect of  lupus nephritis patients.
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